Source: Eur Respir J 2007; 29: 251-258
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Roiha H. L., Kuehni C. E., Zanolari M., Zwahlen M., Baldwin D. N., Casaulta C., Nelle M., Frey U.. Alterations of exhaled nitric oxide in pre-term infants with chronic lung disease. Eur Respir J 2007; 29: 251-258

Member's Comments

No comment yet.

Related content which might interest you: Exhaled nitric oxide output is decreased in preterm infants with chronic lung disease in the post-acute phase Source: Eur Respir J 2004; 24: Suppl. 48, 464s Year: 2004 L-arginine for chronic lung disease (CLD) in preterm neonates Source: Annual Congress 2013 –Neonatal and paediatric intensive care Year: 2013 Exhaled nitric oxide in infants: a marker of inflammation? Source: Eur Respir Monogr 2010; 49: 56-70 Year: 2010 The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma Source: Eur Respir J 2005; 25: 289-294 Year: 2005 Exhaled nitric oxide in respiratory diseases other than asthma Source: Eur Respir Monogr 2010; 49: 45-55 Year: 2010 Fractional exhaled nitric oxide concentration in school-aged children born who had chronic lung disease in infancy Source: International Congress 2018 – Neonatology and paediatric intensive care Year: 2018 Exhaled nitric oxide is not reduced in infants with cystic fibrosis Source: Eur Respir J 2006; 27: 350-354 Year: 2006 Is exhaled nitric oxide in newborns associated with subsequent respiratory symptoms in infancy? Source: Eur Respir J 2006; 28: Suppl. 50, 269s Year: 2006 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide and pulmonary function in children with sickle cell disease Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 Reduced exhaled nitric oxide in infants with cystic fibrosis Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Exhaled nitric oxide after lung transplantation: impact of the native lung Source: Eur Respir J 2003; 21: 429-432 Year: 2003 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Exhaled nitric oxide measured after birth predicts subsequent respiratory infections in infants Source: Eur Respir J 2002; 20: Suppl. 38, 21s Year: 2002 Nitric oxide production by the alveolar compartment of the lungs in cirrhotic patients Source: Eur Respir J 2009; 34: 138-144 Year: 2009 Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Source: Eur Respir J 2006; 28: 1236-1244 Year: 2006 Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases Source: International Congress 2015 – IIPs: orphan Year: 2015 Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011